Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 8/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.50 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.45 |
| ▸ | PTPRC | P08575 | 3/20 | 0.45 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.45 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8974372 | 0.98 | SLC9A1 (0.48) | SLC9A1POLBMAPK1ATMKEAP1 | |
| SCHEMBL20654566 | 0.81 | SLC9A1 (0.44) | SLC9A1POLBMAPK1ATMKEAP1 | |
| SCHEMBL17012578 | 0.80 | POLB (0.47) | SLC9A1POLBMAPK1ATMKEAP1 | |
| SCHEMBL6905682 | 0.79 | SLC9A1 (0.50) | SLC9A1POLBMAPK1ATMKEAP1 | |
| SCHEMBL7760804 | 0.79 | SLC9A1 (0.55) | SLC9A1POLBMAPK1ATMKEAP1 | |
| SCHEMBL23077724 | 0.76 | POLB (0.52) | SLC9A1POLBMAPK1ATMKEAP1 | |
| SCHEMBL21220894 | 0.76 | SLC9A1 (0.52) | SLC9A1POLBMAPK1ATMKEAP1 | |
| SCHEMBL8631035 | 0.76 | MAPT (0.52) | SLC9A1POLBMAPK1ATMKEAP1 | |
| SCHEMBL10607208 | 0.76 | SLC9A1 (0.52) | SLC9A1POLBMAPK1ATMKEAP1 | |
| SCHEMBL28941549 | 0.73 | SMN1; SMN2 (0.51) | ALDH1A1CYP1A2MAPTRAB9AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5573708-A | ACID-SUBSTITUTED PERFLUOROALKYLBENZENES | UNION CHEMICAL CO., LTD. (JP) | 1996-11-12 | — | — | US | claimed |
| EP-0569884-B1 | Rust inhibitor | UNION CHEMICAL CO LTD (JP) | 1996-09-18 | — | — | EP | claimed |
| EP-0569884-A1 | Rust inhibitor | UNION CHEMICAL CO., LTD. (JP) | 1993-11-18 | — | — | EP | claimed |
| EP-2705024-A1 | ALKYNE BENZOTRIAZOLE DERIVATIVES | Merck Sharp & Dohme Corp. (US) | 2014-03-12 | — | — | EP | disclosed |
| EP-1983008-B1 | FLUORINE-CONTAINING POLYMER CONTAINING HETEROAROMATIC RING | DAIKIN IND LTD (JP) | 2012-12-26 | — | — | EP | disclosed |
| WO-2012151139-A1 | ALKYNE BENZOTRIAZOLE DERIVATIVES | MERCK SHARP & DOHME CORP. (US) | 2012-11-08 | — | — | WO | disclosed |
| CN-102272105-A | enantiomerically enriched aryloazol-2-yl cyanoethylamino parasiticidal compounds | — | 2011-12-07 | — | — | CN | disclosed |
| EP-1983008-A1 | FLUORINE-CONTAINING POLYMER CONTAINING HETEROAROMATIC RING | Daikin Industries, Ltd. (JP) | 2008-10-22 | — | — | EP | disclosed |
| US-20070149508-A1 | Six membered heteroaromatic inhibitors targeting resistant kinase mutations | TARGEGEN, INC. (US) | 2007-06-28 | — | — | US | disclosed |
| US-5573708-A | ACID-SUBSTITUTED PERFLUOROALKYLBENZENES | UNION CHEMICAL CO., LTD. (JP) | 1996-11-12 | — | — | US | disclosed |
| EP-0569884-B1 | Rust inhibitor | UNION CHEMICAL CO LTD (JP) | 1996-09-18 | — | — | EP | disclosed |
| US-5487846-A | FLUORINE-SUBSTITUTED BENZENE DERIVATIVES | UNION CHEMICAL CO., LTD. (JP) | 1996-01-30 | — | — | US | disclosed |
| EP-0569884-A1 | Rust inhibitor | UNION CHEMICAL CO., LTD. (JP) | 1993-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070149508-A1 | Six membered heteroaromatic inhibitors targeting resistant kinase mutations | ABL1, KDR, BCR | SLC9A1 4553/4885POLB 1755/4885MAPK1 197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.